Growth inhibition of estrogen-dependent rat mammary cancer by EMD 16-795, a new synthetic anti-estrogen.
D000818:Animals; D001551:Benz(a)Anthracenes; D002277:Carcinoma / Q000139:chemically induced / Q000188:drug therapy* / Q000378:metabolism; D003864:Depression, Chemical; D004965:Estrogen Antagonists; D004967:Estrogens / Q000494:pharmacology; D005260:Female; D005419:Flavonoids / Q000494:pharmacology / Q000627:therapeutic use*; D007529:Isoflavones; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000188:drug therapy* / Q000378:metabolism; D008660:Metabolism / Q000187:drug effects; D011759:Pyrrolidines / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D011955:Receptors, Drug
D001551:Benz(a)Anthracenes; D004965:Estrogen Antagonists; D004967:Estrogens; D005419:Flavonoids; D007529:Isoflavones; D011759:Pyrrolidines; D011955:Receptors, Drug; C001745:EMD 16795